Strategy
Enabling value creation by empowering international companies to expand and control their new business in China.
GIBF partners with selected companies from Israel, Europe and the USA to establish new JVs in the Chinese market, enabling the foreign companies to control and manage their new subsidiaries as the majority shareholders.
Based in the Greater Bay Area of South China, GIBF offers international companies the resources and expertise to create value in their JVs through multiple channels, such as expanding and expediting their global clinical trials, early entry into the Chinese market, IPO in Hong Kong under the new Biotech18-A chapter introduced by the SEHK or similar channels in Chinese stock exchanges, and local M&A and licensing deals.
Unique Value Proposition
01
Proven Investment Model
02
Access to Deal Flow
03
Team
04
Chinese Governmental Backing
01
Proven Investment Model
With years of experience and numerous companies already established, our unique JV investment model brings foreign companies to China and adopts advanced technologies with local demands, integrating global entrepreneurship with Chinese talents, combining risk mitigation with multiple exit options.
02
Access to Deal Flow
Unparalleled access to top tier global early stage and growth innovative high-tech companies.
03
Team
Highly experienced Israel and China based team, with strong track record and exceptional reputation.
04
Chinese Governmental Backing
Chinese Governmental Backing.
Successful Investment Model
Parent Company
The Parent Company provides a full rights for its technology and know-how/expertise for the Chinese market, as well as management
Dual Exit Strategy
1. JV Exit: M&A or public offering in China or Hong-Kong (Chapter 18A Hong Kong Exchanges)
2. Conversion Mechanism: GIBF has the option to convert its shares in the JV into shares of the Parent Company in an exit event of the Parent Company
2. Conversion Mechanism: GIBF has the option to convert its shares in the JV into shares of the Parent Company in an exit event of the Parent Company
The Joint Venture
The joint venture builds end-to-end business operations in China including R&D, manufacturing, marketing and sales, based on a business plan prepared by the Parent Company and agreed by the parties
GIBF
GIBF ensures successful Chinese market access with financial, regulatory, governmental policy, and network support
Unique Deal Flow Sourcing
Cooperate with top tier global VCs, selecting targets suitable for the Chinese market.
Investment Model
GIBF establishes alongside international healthcare companies Joint Ventures in China